OTC : CERO

CERo Therapeutics Holdings, Inc. — Earnings Estimates

$0.011 USD

$0.0 (10.0%)

Volume
56.02K
Average Volume
782K
Market Capitalization
$496.24K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$8.90
Year Low
$0.01
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.14

Annual earnings financials

CERO financial data with annual/quarterly toggle

CERO GAAP EPS - Annual & Quarterly

CERO Sales Revenue - Annual & Quarterly

CERO Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CERO Estimated and Actual Revenue by Quarter
CERO Estimated and Actual EPS by Quarter
CERO Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 0 - - - - - -
2028-09-30 0 - - - - - -
2028-06-30 0 - - - - - -
2028-03-31 0 - - - - - -
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
CERO Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 0 -17.76M -17.76M -17.76M - - -
2028-09-30 0 -16.01M -16.01M -16.01M - - -
2028-06-30 0 -14.88M -14.88M -14.88M - - -
2028-03-31 0 -30.6M -30.6M -30.6M - - -
2027-12-31 0 -25.97M -25.97M -25.97M - - -
2027-09-30 0 -23.42M -23.42M -23.42M - - -
CERO Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 0 - - - 1 -0.6176 -0.6176 -0.6176
2028-09-30 0 - - - 1 -0.5569 -0.5569 -0.5569
2028-06-30 0 - - - 1 -0.5175 -0.5175 -0.5175
2028-03-31 0 - - - 1 -1.064 -1.064 -1.064
2027-12-31 0 - - - 1 -0.9031 -0.9031 -0.9031
2027-09-30 0 - - - 1 -0.8144 -0.8144 -0.8144